METRONIDAZOLE AND TISSUE ZINC/IRON RATIO IN CANCER THERAPY
- 26 June 1976
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 307 (7974), 1407
- https://doi.org/10.1016/s0140-6736(76)93053-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Metronidazole (flagyl), a radiosensitiser of possible clinical use in cancer chemotherapy: Some biochemical and pharmacological considerationsBiochemical Pharmacology, 1976
- Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cellsBritish Journal of Cancer, 1976
- METRONIDAZOLE AND IRON IN CANCER THERAPYThe Lancet, 1976
- Metronidazole (Flagyl): iron catalysed reaction with sulphydryl groups and tumour radiosensitisationNature, 1975
- Metronidazole (“Flagyl”). A radiosensitizer of hypoxic cellsThe British Journal of Radiology, 1974
- ACUTE DRUG ADMINISTRATION AND CANCER CONTROLThe Lancet, 1974
- Radiosensitization of anoxic cells by metronidazoleThe British Journal of Radiology, 1973